Chaisson RE - Search Results

1

Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity.

Sterling TR, Chaisson RE, Moore RD. Sterling TR, et al. Among authors: chaisson re. Clin Infect Dis. 2003 Mar 15;36(6):812-5. doi: 10.1086/367934. Epub 2003 Feb 27. Clin Infect Dis. 2003. PMID: 12627368

2

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.

Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Sulkowski MS, et al. Among authors: chaisson re. Hepatology. 2002 Jan;35(1):182-9. doi: 10.1053/jhep.2002.30319. Hepatology. 2002. PMID: 11786975

3

Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors.

Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Oursler KK, et al. Among authors: chaisson re. Clin Infect Dis. 2002 Mar 15;34(6):752-9. doi: 10.1086/338784. Epub 2002 Feb 7. Clin Infect Dis. 2002. PMID: 11850859

4

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Lucas GM, Gebo KA, Chaisson RE, Moore RD. Lucas GM, et al. Among authors: chaisson re. AIDS. 2002 Mar 29;16(5):767-74. doi: 10.1097/00002030-200203290-00012. AIDS. 2002. PMID: 11964533

5

Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations.

Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, Bishai WR. Bellete B, et al. Among authors: chaisson re. Clin Infect Dis. 2002 Jun 1;34(11):1449-56. doi: 10.1086/340397. Epub 2002 May 10. Clin Infect Dis. 2002. PMID: 12015690

6

Hepatitis C and progression of HIV disease.

Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Sulkowski MS, et al. Among authors: chaisson re. JAMA. 2002 Jul 10;288(2):199-206. doi: 10.1001/jama.288.2.199. JAMA. 2002. PMID: 12095384

7

Tuberculosis drug resistance: a global threat.

Nachega JB, Chaisson RE. Nachega JB, et al. Among authors: chaisson re. Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S24-30. doi: 10.1086/344657. Clin Infect Dis. 2003. PMID: 12516027

8

Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.

Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, Page-Shipp L, Karp CL, Sterling TR, Quinn TC, Chaisson RE. Morris L, et al. Among authors: chaisson re. J Infect Dis. 2003 Jun 15;187(12):1967-71. doi: 10.1086/375346. Epub 2003 Jun 4. J Infect Dis. 2003. PMID: 12792875 Clinical Trial.

9

Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.

Lucas GM, Chaisson RE, Moore RD. Lucas GM, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):321-8. doi: 10.1097/00126334-200307010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12843742

10

The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.

Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. Mehta SH, et al. Among authors: chaisson re. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):577-84. doi: 10.1097/00126334-200308150-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12902801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters